{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lutrepulse&page=8", "query": { "intervention": "Lutrepulse", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 431, "total_pages": 44, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lutrepulse&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lutrepulse&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T12:56:20.834Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03298087", "title": "Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Newly Diagnosed Oligometastatic Prostate Cancer" ], "interventions": [ { "name": "radical prostatectomy", "type": "PROCEDURE" }, { "name": "stereotactic body radiotherapy", "type": "RADIATION" }, { "name": "Leuprolide", "type": "DRUG" }, { "name": "apalutamide", "type": "DRUG" }, { "name": "abiraterone", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "RADIATION", "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 28, "start_date": "2018-07-01", "completion_date": "2024-03-31", "has_results": true, "last_update_posted_date": "2025-08-01", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 3, "location_summary": "Long Beach, California • West Los Angeles, California • Richmond, Virginia", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "West Los Angeles", "state": "California" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03298087" }, { "nct_id": "NCT02949284", "title": "Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stage II Prostate Adenocarcinoma", "Stage III Prostate Adenocarcinoma" ], "interventions": [ { "name": "Abiraterone Acetate", "type": "DRUG" }, { "name": "Androgen Receptor Antagonist ARN-509", "type": "DRUG" }, { "name": "Gonadotropin-releasing Hormone Analog", "type": "BIOLOGICAL" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Radical Prostatectomy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER", "PROCEDURE" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "MALE", "summary": "Male only" }, "enrollment_count": 90, "start_date": "2017-06-20", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 2, "location_summary": "New Haven, Connecticut • New Brunswick, New Jersey", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02949284" }, { "nct_id": "NCT00220194", "title": "A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cancer of Prostate" ], "interventions": [ { "name": "leuprolide acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "San Bernardino Urological Associates Medical Group Inc", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 100, "start_date": "2003-04", "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2016-10-14", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 1, "location_summary": "San Bernardino, California", "locations": [ { "city": "San Bernardino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00220194" }, { "nct_id": "NCT00002881", "title": "Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "flutamide", "type": "DRUG" }, { "name": "goserelin acetate", "type": "DRUG" }, { "name": "leuprolide acetate", "type": "DRUG" }, { "name": "suramin", "type": "DRUG" }, { "name": "therapeutic hydrocortisone", "type": "DRUG" }, { "name": "orchiectomy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Eastern Cooperative Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": null, "start_date": "1996-10", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-11-09", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002881" }, { "nct_id": "NCT03093272", "title": "A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Leuprolide Acetate", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "Apalutamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 9, "start_date": "2017-06-23", "completion_date": "2019-12-31", "has_results": true, "last_update_posted_date": "2020-04-09", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03093272" }, { "nct_id": "NCT04126070", "title": "Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hormone Sensitive Prostate Cancer", "Prostate Adenocarcinoma", "Metastasis Prostate Adenocarcinoma" ], "interventions": [ { "name": "Androgen Deprivation Therapy", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Xiao X. Wei, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 47, "start_date": "2020-05-11", "completion_date": "2026-10-30", "has_results": true, "last_update_posted_date": "2026-08-12", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 6, "location_summary": "La Jolla, California • Tampa, Florida • Baltimore, Maryland + 2 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04126070" }, { "nct_id": "NCT01846728", "title": "Effects of Estrogen Deficiency on Energy Expenditure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Estrogen suppression", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "20 Years to 40 Years · Female only" }, "enrollment_count": 6, "start_date": "2013-04", "completion_date": "2016-10", "has_results": true, "last_update_posted_date": "2019-11-18", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01846728" }, { "nct_id": "NCT00903162", "title": "Extended Endocrine Therapy for Premenopausal Women With Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "leuprolide", "type": "DRUG" }, { "name": "letrozole", "type": "DRUG" }, { "name": "zoledronic acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 17, "start_date": "2009-05", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2016-04-18", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 4, "location_summary": "Denver, Colorado • Boston, Massachusetts • Newton, Massachusetts", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Newton", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00903162" }, { "nct_id": "NCT01415960", "title": "Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Leuprolide acetate 22.5 mg depot, GP-Pharm SA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GP-Pharm", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 163, "start_date": "2011-09", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2017-03-03", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 25, "location_summary": "San Diego, California • Daytona Beach, Florida • Ocala, Florida + 22 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01415960" }, { "nct_id": "NCT04787744", "title": "Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Prostate Cancer", "Oligometastasis", "Oligorecurrence", "Recurrent Prostate Cancer", "Metastatic Prostate Cancer", "De Novo Prostate Cancer" ], "interventions": [ { "name": "PET-directed Local Therapy using Surgery", "type": "PROCEDURE" }, { "name": "PET-directed Local Therapy using Radiation", "type": "RADIATION" }, { "name": "Salvage Local Therapy for locally recurrent disease", "type": "OTHER" }, { "name": "Goserelin, Histrelin, Leuprolide & Triptorelin", "type": "DRUG" }, { "name": "ADT + Nilutamide, Flutamide, & Bicalutamide", "type": "DRUG" }, { "name": "Degarelix & Relugolix", "type": "DRUG" }, { "name": "ADT + Docetaxel +/- prednisone", "type": "DRUG" }, { "name": "ADT + Abiraterone + Prednisone", "type": "DRUG" }, { "name": "ADT + Abiraterone + Methylprednisolone", "type": "DRUG" }, { "name": "ADT + Apalutamide", "type": "DRUG" }, { "name": "ADT + Enzalutamide", "type": "DRUG" }, { "name": "Prostate-directed Radiation for De novo oligometastatic prostate cancer", "type": "RADIATION" } ], "intervention_types": [ "PROCEDURE", "RADIATION", "OTHER", "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 378, "start_date": "2021-07-01", "completion_date": "2029-03-30", "has_results": false, "last_update_posted_date": "2026-10-19", "last_synced_at": "2026-10-24T12:56:20.834Z", "location_count": 20, "location_summary": "Long Beach, California • West Los Angeles, California • Washington D.C., District of Columbia + 17 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "West Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Bay Pines", "state": "Florida" }, { "city": "Hines", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04787744" } ] }